Literature DB >> 16476138

Seizure threshold determination for electroconvulsive therapy: stimulus dose titration versus age-based estimations.

John W G Tiller1, Nicholas Ingram.   

Abstract

OBJECTIVE: This study compared electroconvulsive therapy (ECT) seizure threshold determined by stimulus dose titration with age-based estimations.
METHOD: Patients with major depressive disorder had their initial seizure thresholds determined by stimulus dose titration and the results compared with age-based estimations. There are no significant differences in thresholds determined by these methods.
RESULTS: Two hundred and three psychiatric patients (149 females, 54 males) had their seizure thresholds determined by stimulus dose titration. There was a significant positive correlation between seizure thresholds and age for males and females with male thresholds greater than female thresholds. Age determinations of seizure threshold would have resulted in excessive initial treatment stimuli for 30% of females and 8% of males. Ineffective stimulus doses would have been given to 2% of females and 7% of males on a full age basis and 64% using a half age strategy.
CONCLUSIONS: For effective high-dose right unilateral ECT, initial seizure threshold should be determined by stimulus dose titration.

Entities:  

Mesh:

Year:  2006        PMID: 16476138     DOI: 10.1080/j.1440-1614.2006.01773.x

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  8 in total

Review 1.  Meta-analysis of initial seizure thresholds in electroconvulsive therapy.

Authors:  Jeroen A van Waarde; Bastiaan Verwey; Rose C van der Mast
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-04-21       Impact factor: 5.270

2.  Electroconvulsive practice in Singapore: a cross-sectional national survey.

Authors:  Phern-Chern Tor; Verònica Gálvez; Aaron Ang; Johnson Fam; Herng-Nieng Chan; Sheng-Neng Tan; Colleen K Loo
Journal:  Singapore Med J       Date:  2019-06-14       Impact factor: 1.858

3.  Seizure threshold in a large sample: implications for stimulus dosing strategies in bilateral electroconvulsive therapy: a report from CORE.

Authors:  Georgios Petrides; Raphael J Braga; Max Fink; Martina Mueller; Rebecca Knapp; Mustafa Husain; Teresa Rummans; Samuel Bailine; Chitra Malur; Kevin O'Connor; Charles Kellner
Journal:  J ECT       Date:  2009-12       Impact factor: 3.635

4.  Successful Electroconvulsive Therapy for a 74-year-old Female with Major Depressive Disorder and Tardive Tremor: A Case Report and Literature Review.

Authors:  Jia-Yin Yeh; Nien-Mu Chiu; Yung-Yee Chang; Pao-Yen Lin; Yu Lee
Journal:  Clin Psychopharmacol Neurosci       Date:  2020-05-31       Impact factor: 2.582

5.  Initial Seizure Threshold in Brief-Pulse Bilateral Electroconvulsive Therapy in Patients with Schizophrenia or Schizoaffective Disorder.

Authors:  Seong Hoon Jeong; Tak Youn; Younsuk Lee; Jin Hyeok Jang; Young Wook Jeong; Yong Sik Kim; In Won Chung
Journal:  Psychiatry Investig       Date:  2019-08-21       Impact factor: 2.505

6.  Effect of age and anticonvulsants on seizure threshold during bilateral electroconvulsive therapy with brief-pulse stimulus: A chart-based analysis.

Authors:  Abhishek R Nitturkar; Preeti Sinha; Virupakshappa I Bagewadi; Jagadisha Thirthalli
Journal:  Indian J Psychiatry       Date:  2016 Apr-Jun       Impact factor: 1.759

7.  S100B, Homocysteine, Vitamin B12, Folic Acid, and Procalcitonin Serum Levels in Remitters to Electroconvulsive Therapy: A Pilot Study.

Authors:  Hannah Maier; Saskia Helm; Sermin Toto; Nicole Moschny; Wolfgang Sperling; Thomas Hillemacher; Kai G Kahl; Ewgeni Jakubovski; Stefan Bleich; Helge Frieling; Alexandra Neyazi
Journal:  Dis Markers       Date:  2018-01-10       Impact factor: 3.434

8.  Stimulus intensity determined by dose-titration versus age-based methods in electroconvulsive therapy in Thai patients.

Authors:  Pichai Ittasakul; Apichaya Likitnukul; Umporn Pitidhrammabhorn; Punjaporn Waleeprakhon; Morris B Goldman
Journal:  Neuropsychiatr Dis Treat       Date:  2019-02-07       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.